Home » Topics » BioWorld Science

BioWorld Science
RSS

Myelin needs just the right amount of neighborliness

Dec. 19, 2018

Eli Lilly patents OGA inhibitors

Dec. 19, 2018

Spiral Therapeutics initiates phase I trial of new hearing loss drug, LPT-99

Dec. 19, 2018

Topline data presented from phase Ia study of LX-9211

Dec. 19, 2018

First patient enrolled in pivotal phase III AGENT study of arfolitixorin

Dec. 19, 2018

Positive phase II data presented in third proof-of-concept study of VX-150

Dec. 19, 2018

Corbus initiates phase III DETERMINE study based on phase II data in dermatomyositis

Dec. 19, 2018

TK-90 shows promise for prevention of mucositis in clinical study

Dec. 19, 2018

Pyramid Biosciences licenses TRK modulator from AstraZeneca

Dec. 19, 2018

Selatogrel significantly inhibits platelet aggregation in phase II studies

Dec. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...